U.S. Food and Drug Administration Approval of AmBisome...

Clinical Infectious Diseases 1999 / 04 Vol. 28; Iss. 1

U.S. Food and Drug Administration Approval of AmBisome (Liposomal Amphotericin B) for Treatment of Visceral Leishmaniasis

Andrea Meyerhoff
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Clinical Infectious Diseases
DOI:
10.2307/4460628
Date:
April, 1999
File:
PDF, 433 KB
english, 1999
Conversion to is in progress
Conversion to is failed